世界のバイオバンク市場は、2019年に約659億米ドルとなっており、2020年から2027年の予測期間に6.30％以上の健全な成長率が見込まれています。バイオバンクとは、生物資源を収集・保管し、診断や生態系調査、分析に利用するための方法です。世界のバイオバンク産業の成長を促す要因として、民間企業や政府機関からの資金援助の拡大が挙げられます。加えて、慢性疾患の罹患率の改善が需要の増加を促しています。しかし、バイオバンクに関する倫理的・規制的な懸念が事業拡大の妨げとなっています。COVID-19パンデミックの発生により、世界中でバイオバンクの関連性がクローズアップされています。その結果、COVID-19バイオバンクが世界的に急速に構築され、新型SARS-CoV-2ウイルスへの感染が報告されているCOVID-19患者から研究用の生物資源や関連する臨床・患者データが前向きに選択され、質の高い研究が可能になったのです。例えば、厚生省のNHRIバイオバンクは、2020年2月初旬にCOVID-19バイオバンクを作成し、台湾の研究者や産業界のためにCOVID-19患者の血液サンプルを発展的に収集することになりました。この2つの側面が、今後のバイオバンク業界に影響を与えると予測されます。また、パンデミックの発生も、バイオバンク市場の拡大に好影響を与えています。癌、心血管疾患、神経疾患、免疫疾患などのいくつかの慢性疾患は、副作用のために従来の治療法では治療できません。これらの副作用のリスクは、幹細胞治療に組み込むことで最小限に抑えることができます。幹細胞治療は、治療用量によって引き起こされる害を軽減するための治療薬として機能します。国立癌センターの数字によると、2019年に米国では約950万人が癌に罹患していることが確認されており、この数字は2024年には1,900万人になると予測されています。ゆえに、臍帯血の医療目的の需要が高まり、バイオバンク市場の発展を刺激しています。
世界のバイオバンク市場の地域分析は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域といった主要地域を対象にしています。アジア太平洋地域は、人口の増加と大きな高齢者層の存在により、バイオバンク業界で活動する大手企業にとって魅力的な展望があります。さらに、医療費の増加やガイドラインの策定が、国内の需要拡大につながると期待されています。
この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資するミクロ市場での機会についても報告します。
目次
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Biobanks Market, by Region, 2018-2027 (USD Billion)
1.2.2. Biobanks Market, by Sample Type, 2018-2027 (USD Billion)
1.2.3. Biobanks Market, by Product and Services, 2018-2027 (USD Billion)
1.2.4. Biobanks Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biobanks Market Definition & Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biobanks Market Dynamics
3.1. Biobanks Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Biobanks Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Biobanks Market, by Sample Type
5.1. Market Snapshot
5.2. Global Biobanks Market by Sample Type, Performance - Potential Analysis
5.3. Global Biobanks Market Estimates & Forecasts by Sample Type, 2017-2027 (USD Billion)
5.4. Biobanks Market, Sub Segment Analysis
5.4.1. Blood Products
5.4.2. Solid Tissue
5.4.3. Cell Lines
5.4.4. Nucleic Acid
5.4.5. Others
Chapter 6. Global Biobanks Market, by Product and Services
6.1. Market Snapshot
6.2. Global Biobanks Market by Product and Services, Performance - Potential Analysis
6.3. Global Biobanks Market Estimates & Forecasts by Product and Services, 2017-2027 (USD Billion)
6.4. Equipment
6.5. Consumables
6.6. Services
6.7. Software
Chapter 7. Global Biobanks Market, by Application
7.1. Market Snapshot
7.2. Global Biobanks Market by Application, Performance - Potential Analysis
7.3. Global Biobanks Market Estimates & Forecasts by Application, 2017-2027 (USD Billion)
7.4. Regenerative Medicine
7.5. Life Science Research
7.6. Clinical Research
Chapter 8. Global Biobanks Market, Regional Analysis
8.1. Biobanks Market, Regional Market Snapshot
8.2. North America Biobanks Market
8.2.1. U.S. Biobanks Market
8.2.1.1. Sample Type breakdown estimates & forecasts, 2017-2027
8.2.1.2. Product and Services breakdown estimates & forecasts, 2017-2027
8.2.1.3. Application breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Biobanks Market
8.3. Europe Biobanks Market Snapshot
8.3.1. U.K. Biobanks Market
8.3.2. Germany Biobanks Market
8.3.3. France Biobanks Market
8.3.4. Spain Biobanks Market
8.3.5. Italy Biobanks Market
8.3.6. Rest of Europe Biobanks Market
8.4. Asia-Pacific Biobanks Market Snapshot
8.4.1. China Biobanks Market
8.4.2. India Biobanks Market
8.4.3. Japan Biobanks Market
8.4.4. Australia Biobanks Market
8.4.5. South Korea Biobanks Market
8.4.6. Rest of Asia Pacific Biobanks Market
8.5. Latin America Biobanks Market Snapshot
8.5.1. Brazil Biobanks Market
8.5.2. Mexico Biobanks Market
8.6. Rest of The World Biobanks Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Industry Summary
9.2.1.5. Recent Developments
9.2.2. Panasonic Healthcare Holdings Co., Ltd.
9.2.3. Becton, Dickinson and Company
9.2.4. Qiagen N.V.
9.2.5. Merck KGaA
9.2.6. VWR Corporation
9.2.7. Tecan Trading AG
9.2.8. Brooks Automation, Inc.
9.2.9. Chart Industries, Inc.
9.2.10. Hamilton Company
9.2.11. Greiner Holding AG
9.2.12. Promega Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. GLOBAL BIOBANKS MARKET, REPORT SCOPE
TABLE 2. GLOBAL BIOBANKS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL BIOBANKS MARKET ESTIMATES & FORECASTS BY SAMPLE TYPE 2017-2027 (USD BILLION)
TABLE 4. GLOBAL BIOBANKS MARKET ESTIMATES & FORECASTS BY PRODUCT AND SERVICES 2017-2027 (USD BILLION)
TABLE 5. GLOBAL BIOBANKS MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD BILLION)
TABLE 6. GLOBAL BIOBANKS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 7. GLOBAL BIOBANKS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL BIOBANKS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL BIOBANKS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL BIOBANKS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL BIOBANKS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL BIOBANKS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL BIOBANKS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. GLOBAL BIOBANKS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. GLOBAL BIOBANKS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 16. U.S. BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 17. U.S. BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 18. U.S. BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 19. CANADA BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 20. CANADA BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 21. CANADA BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 22. UK BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 23. UK BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 24. UK BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 25. GERMANY BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 26. GERMANY BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 27. GERMANY BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 28. ROE BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 29. ROE BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 30. ROE BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 31. CHINA BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 32. CHINA BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 33. CHINA BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 34. INDIA BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 35. INDIA BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 36. INDIA BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 37. JAPAN BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 38. JAPAN BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 39. JAPAN BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 40. ROAPAC BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 41. ROAPAC BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 42. ROAPAC BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 43. BRAZIL BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 44. BRAZIL BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 45. BRAZIL BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 46. MEXICO BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 47. MEXICO BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 48. MEXICO BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 49. ROLA BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 50. ROLA BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 51. ROLA BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 52. ROW BIOBANKS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 53. ROW BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 54. ROW BIOBANKS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 55. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BIOBANKS MARKET
TABLE 56. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BIOBANKS MARKET
TABLE 57. YEARS CONSIDERED FOR THE STUDY
TABLE 58. EXCHANGE RATES CONSIDERED
List of Figures
FIG 1. GLOBAL BIOBANKS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL BIOBANKS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL BIOBANKS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL BIOBANKS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL BIOBANKS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL BIOBANKS MARKET, PEST ANALYSIS
FIG 8. GLOBAL BIOBANKS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL BIOBANKS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL BIOBANKS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL BIOBANKS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL BIOBANKS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL BIOBANKS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL BIOBANKS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA BIOBANKS MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE BIOBANKS MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC BIOBANKS MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA BIOBANKS MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL BIOBANKS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
